期刊
AMERICAN JOURNAL OF PATHOLOGY
卷 182, 期 2, 页码 485-504出版社
ELSEVIER SCIENCE INC
DOI: 10.1016/j.ajpath.2012.10.018
关键词
-
类别
资金
- Swiss National Science Foundation [3100A0-109981]
- REQUIP grant [326000-121314/1]
- Duchenne Parent Project-The Netherlands (DPP-NL) [S17474 DPP 2011-12]
- Association Francaise contre les Myopathies (AFM) [13090, 13984, 15093]
- AFM [13091]
- National Institute of Child Health & Human Development
Duchenne muscular dystrophy (DMD) is a severe disorder characterized by progressive muscle wasting, respiratory and cardiac impairments, and premature death. No treatment exists so far, and the identification of active substances to fight DMD is urgently needed. We found that tamoxifen, a drug used to treat estrogen-dependent breast cancer, caused remarkable improvements of muscle force and of diaphragm and cardiac structure in the mdx(5Cv) mouse model of DMD. Oral tamoxifen treatment from 3 weeks of age for 15 months at a dose of 10 mg/kg/day stabilized myofiber membranes, normalized whole body force, and increased force production and resistance to repeated contractions of the triceps muscle above normal values. Tamoxifen improved the structure of leg muscles and diminished cardiac fibrosis by similar to 50%. Tamoxifen also reduced fibrosis in the diaphragm, while increasing its thickness, myofiber count, and myofiber diameter, thereby augmenting by 72% the amount of contractile tissue available for respiratory function. Tamoxifen conferred a markedly slower phenotype to the muscles. Tamoxifen and its metabolites were present in nanomolar concentrations in plasma and muscles, suggesting signaling through high-affinity targets. Interestingly, the estrogen receptors ER alpha and ER beta were several times more abundant in dystrophic than in normal muscles, and tamoxifen normalized the relative abundance of ER beta isoforms. Our findings suggest that tamoxifen might be a useful therapy for DMD. (Am J Pathol 2013, 182: 485-504; http://dx.doi.org/10.1016/j.ajpath.2012.10.018)
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据